Immunic to present MS drug data at Toronto conference

October 7, 2026 8:00 AM

Immunic, Inc. (Nasdaq: IMUX) announced that four abstracts on its investigational drug vidofludimus calcium (IMU-838) have been accepted for presentation ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found